BILTHOVEN, Netherlands, Sept. 16, 2021 /PRNewswire/ -- Intravacc, a global leader in translational research and the development of vaccines against infectious diseases and therapeutic vaccines, today launches its new hybrid business model that should lead to further innovation and...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]tion-and-growth-301378153.html